Barclays Reiterates an 'Underweight' on Cintas (CTAS); Mixed 2Q: Revenue Better, but Margins Weak; Stock Expensive
Tweet Send to a Friend
Barclays reiterates an 'Underweight' on Cintas (NASDAQ: CTAS), PT $24.
Barclays analyst says, "Last night, Cintas reported mixed 2Q results ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Last night, Cintas reported mixed 2Q results ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
